New Zealand Scientists Work On Cheaper, Low Side-Effects TNBC Drug
This article was originally published in PharmAsia News
Executive Summary
New Zealand researchers are working on a low-cost chemotherapy drug to treat triple-negative breast cancer without killing nearby healthy cells, a side effect that causes sickness and hair loss.